ArticleFrontiers in immunology2026

Dermatological and gastrointestinal adverse reactions in ocrelizumab treated patients with multiple sclerosis: a case series.

Lena K Höpner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.